TABLE 1.

Samples of available resources

Resources	Contents
Guidance for economic studies	Drummond and colleagues (2015) Methods for the economic evaluation of healthcare programmes. 8 International Decision Support Initiative (iDSI) (2016) Reference case for economic evaluation. 9 World Health Organization (WHO) (2019) WHO guide on standardisation of economic evaluations of immunisation programmes. 10
Costing tools	Centre for Disease Control Priority Actions Costing Tool (PACT). 11 International Health Regulations Costing Tool (Georgetown University). 12 One Health Tool (Avenir Health). 13 WHO National Action Planning for Health Security (NAPHS) planning and costing tool. 14 Review of available tools: Lee and colleagues (2020) Action‐based costing for national action plans for health security. 11
Economic impact studies	COVID‐19 Chen and colleagues (2020) The impact of the COVID‐19 pandemic on consumption: learning from high frequency transaction data. 15 Eichenbaum and colleagues (2020) The macroeconomics of epidemics. 16 General Bartsch and colleagues (2015) The cost of an Ebola case. 17 Fonseca and colleagues (2009) Impact of a natural disaster on diabetes. 18 Joo and colleagues (2019) Economic impact of the 2015 MERS outbreak on the Republic of Korea's tourism‐related industries. 19
Economic evaluations	COVID‐19 De Walque and colleagues (2020) How two tests can help contain COVID‐19 and revive the economy. 20 Wang and colleagues (2020) Effectiveness and cost‐effectiveness of public health measures to control COVID‐19: a modelling study. 21 General Carrasco and colleagues (2011) Strategies for antiviral stockpiling for future influenza pandemics. 22 Dorratoltaj and colleagues (2017) Epidemiological and economic impact of pandemic influenza in Chicago: priorities for vaccine interventions. 23 Wong and colleagues (2016) Economic evaluation of individual school closure strategies: the Hong Kong 2009 H1N1 pandemic. 24
Evidence reviews	Huber and colleagues (2018) The economic and social burden of the 2014 Ebola outbreak in West Africa. 4 Ott and colleagues (2013) Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. 25 Pasquini‐Descomps and colleagues (2017) Value for money in H1N1 influenza: a systematic review of the cost‐effectiveness of pandemic interventions. 3

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.